StonvexLoading…
StonvexStonvexStonvexCore line items from ARW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $9.66B | $9.47B | $30.85B | $22.11B | $14.39B |
Operating Income | Not available | $361.60M | $822.22M | $528.15M | $349.14M |
Net Income | Not available | $235.11M | $571.27M | $376.66M | $267.47M |
EPS (Diluted) | $4.50 | $4.55 | $10.93 | $7.19 | $5.09 |
Total Assets | Not available | $35.95B | $29.08B | $24.53B | $24.25B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $286.51M | $306.47M | $213.61M | $221.97M |
Free Cash Flow OCF − CapEx | Not available | $667.64M | $-37.20M | $-209.77M | $102.19M |
Shares Outstanding | Not available | 51.71M | 52.26M | 52.38M | 52.50M |